Loading
Latest filing published 04 Sept 2026 for Enliven Therapeutics, Inc., €1.9M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Heyman Richard A. has a single filing on record, published on 4 September 2026: a transaction of €1.9M in Enliven Therapeutics, Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration